Literature DB >> 19219580

Multifarious proteomic signatures and regional heterogeneity in glioblastomas.

Chul-Kee Park1, Ji Hye Jung, Sung-Hye Park, Hee-Won Jung, Byung-Kyu Cho.   

Abstract

To investigate the underlying intratumoral diversity of molecular profiles in glioblastomas, a proteomic approach was introduced to compare samples from regions of different histological grade. Using two-dimensional gel electrophoresis (2DE) with matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), we compared prospectively collected tissue samples of different histological grade areas of three glioblastoma patients. Consistent results showing relatively high expression of ubiquitin carboxyl-terminal esterase L1 in low-histological-grade areas (Grade 2 > Grades 3 and 4) and high expression of transthyretin in high-histological-grade areas (Grade 2 < Grades 3 and 4) were demonstrated. These results were confirmed by western blot (WB) analysis and immunohistochemical staining. This study provided the evidence of multifarious proteomic signatures according to regional and histological heterogeneity in glioblastomas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19219580     DOI: 10.1007/s11060-009-9805-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  53 in total

1.  c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells.

Authors:  R Gavioli; T Frisan; S Vertuani; G W Bornkamm; M G Masucci
Journal:  Nat Cell Biol       Date:  2001-03       Impact factor: 28.824

2.  Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.

Authors:  Dominique B Hoelzinger; Luigi Mariani; Joachim Weis; Tanja Woyke; Theresa J Berens; Wendy S McDonough; Andrew Sloan; Stephen W Coons; Michael E Berens
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

3.  Proteomic studies on low- and high-grade human brain astrocytomas.

Authors:  Federico Odreman; Marco Vindigni; Marlen Lujardo Gonzales; Benedetta Niccolini; Giovanni Candiano; Bruno Zanotti; Miran Skrap; Stefano Pizzolitto; Giorgio Stanta; Alessandro Vindigni
Journal:  J Proteome Res       Date:  2005 May-Jun       Impact factor: 4.466

4.  Frequent mitotic errors in tumor cells of genetically micro-heterogeneous glioblastomas.

Authors:  S Loeper; B F Romeike; N Heckmann; V Jung; W Henn; W Feiden; K D Zang; S Urbschat
Journal:  Cytogenet Cell Genet       Date:  2001

5.  Genetic analysis of human glioblastomas using a genomic microarray system.

Authors:  Tsuyoshi Suzuki; Motohiko Maruno; Kouichi Wada; Naoki Kagawa; Yasunori Fujimoto; Naoya Hashimoto; Shuichi Izumoto; Toshiki Yoshimine
Journal:  Brain Tumor Pathol       Date:  2004       Impact factor: 3.298

6.  Protein gene product 9.5 (PGP 9.5) is not a specific marker of neural and nerve sheath tumors: an immunohistochemical study of 95 mesenchymal neoplasms.

Authors:  Lucas K Campbell; J Roby Thomas; Laura W Lamps; Bruce R Smoller; Andrew L Folpe
Journal:  Mod Pathol       Date:  2003-10       Impact factor: 7.842

7.  Identification of noninvasive imaging surrogates for brain tumor gene-expression modules.

Authors:  Maximilian Diehn; Christine Nardini; David S Wang; Susan McGovern; Mahesh Jayaraman; Yu Liang; Kenneth Aldape; Soonmee Cha; Michael D Kuo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-24       Impact factor: 11.205

8.  Genetic intratumour heterogeneity in high-grade brain tumours is associated with telomere-dependent mitotic instability.

Authors:  C Glanz; J Rebetz; Y Stewénius; A Persson; E Englund; N Mandahl; F Mertens; L G Salford; B Widegren; X Fan; D Gisselsson
Journal:  Neuropathol Appl Neurobiol       Date:  2007-08       Impact factor: 8.090

Review 9.  The functions of UCH-L1 and its relation to neurodegenerative diseases.

Authors:  Rieko Setsuie; Keiji Wada
Journal:  Neurochem Int       Date:  2007-05-24       Impact factor: 3.921

10.  Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells.

Authors:  Huib Ovaa; Benedikt M Kessler; Ulrika Rolén; Paul J Galardy; Hidde L Ploegh; Maria G Masucci
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

View more
  10 in total

1.  Rapid T cell-based identification of human tumor tissue antigens by automated two-dimensional protein fractionation.

Authors:  Philipp Beckhove; Rolf Warta; Britt Lemke; Diana Stoycheva; Frank Momburg; Martina Schnölzer; Uwe Warnken; Hubertus Schmitz-Winnenthal; Rezvan Ahmadi; Gerhard Dyckhoff; Mariana Bucur; Simone Jünger; Thomas Schueler; Volker Lennerz; Thomas Woelfel; Andreas Unterberg; Christel Herold-Mende
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

Review 2.  Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas.

Authors:  Fang Shen; Yang Zhang; Yu Yao; Wei Hua; Hai-Shi Zhang; Jing-Song Wu; Ping Zhong; Liang-Fu Zhou
Journal:  Neurosurg Rev       Date:  2014-05-01       Impact factor: 3.042

Review 3.  Proteomics of gliomas: initial biomarker discovery and evolution of technology.

Authors:  Juliya Kalinina; Junmin Peng; James C Ritchie; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2011-09       Impact factor: 12.300

4.  Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach.

Authors:  Brigitte Collet; Nathalie Guitton; Stephan Saïkali; Tony Avril; Charles Pineau; Abderrahmane Hamlat; Jean Mosser; Véronique Quillien
Journal:  Proteome Sci       Date:  2011-04-06       Impact factor: 2.480

Review 5.  Recent advances in the molecular understanding of glioblastoma.

Authors:  Fonnet E Bleeker; Remco J Molenaar; Sieger Leenstra
Journal:  J Neurooncol       Date:  2012-01-20       Impact factor: 4.130

6.  Cluster and Principal Component Analysis of Human Glioblastoma Multiforme (GBM) Tumor Proteome.

Authors:  Mehdi Pooladi; Mostafa Rezaei-Tavirani; Mehrdad Hashemi; Saeed Hesami-Tackallou; Solmaz Khaghani-Razi-Abad; Afshin Moradi; Ali Reza Zali; Masoumeh Mousavi; Leila Firozi-Dalvand; Azadeh Rakhshan; Mona Zamanian Azodi
Journal:  Iran J Cancer Prev       Date:  2014

7.  Proteins inform survival-based differences in patients with glioblastoma.

Authors:  L C Stetson; Quinn T Ostrom; Daniela Schlatzer; Peter Liao; Karen Devine; Kristin Waite; Marta E Couce; Peggy L R Harris; Amber Kerstetter-Fogle; Michael E Berens; Andrew E Sloan; Mohammad M Islam; Vilashini Rajaratnam; Shama P Mirza; Mark R Chance; Jill S Barnholtz-Sloan
Journal:  Neurooncol Adv       Date:  2020-03-17

8.  AEBP1 as a potential immune-related prognostic biomarker in glioblastoma: a bioinformatic analyses.

Authors:  Mingjian Liu; Yuyu Yu; Ziqian Zhang; Zhenghong Chen; Bin Chen; Yijun Cheng; Yongxu Wei; Jia Li; Hanbing Shang
Journal:  Ann Transl Med       Date:  2021-11

Review 9.  Exploring glioblastoma stem cell heterogeneity: Immune microenvironment modulation and therapeutic opportunities.

Authors:  Amanda L Johnson; John Laterra; Hernando Lopez-Bertoni
Journal:  Front Oncol       Date:  2022-09-21       Impact factor: 5.738

10.  Alterations in cerebrospinal fluid proteins in a presymptomatic primary glioma model.

Authors:  John C Whitin; Taichang Jang; Milton Merchant; Tom T-S Yu; Kenneth Lau; Benjamin Recht; Harvey J Cohen; Lawrence Recht
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.